MAHER KHALAF: Open Payments
NPI 1679050983 · TAMPA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$490 in 16 payments from 8 companies in 2025. Trend: 2023 $174 · 2024 $244 · 2025 $490
Food & beverage: $490
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 6 | $246 |
| Edwards Lifesciences Corporation | 3 | $97 |
| AstraZeneca Pharmaceuticals LP | 1 | $33 |
| Amgen Inc. | 2 | $32 |
| Novo Nordisk Inc | 1 | $22 |
| PFIZER INC. | 1 | $21 |
| Lilly USA, LLC | 1 | $20 |
| Novartis Pharmaceuticals Corporation | 1 | $18 |
Products named: WATCHMAN FLX, FARXIGA, PASCAL, SAPIEN 3 Ultra RESILIA, Ozempic, VYNDAQEL, ZEPBOUND, LEQVIO.
Industry payments across FL — which companies pay providers there.
